Recent studies have also shown the involvement of PI3K in abnormal KIT signaling due to activating KIT mutation (KITD816V in human and KITD814V in mouse), which causes hematologic malignancies including mastocytosis and mast cell leukemia [22], [23]. Here, KIT is linked to mast cell leukemia.